Coverage
-
August 27, 2014
A Washington, D.C., federal judge on Wednesday rejected requests from Pharmaceutical Research and Manufacturers of America to invalidate a new interpretive rule involving so-called orphan drugs in the 340B drug discount program, saying the trade group must bring a new lawsuit to proceed.
4 other articles on this case.
View all »